Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Ob Aub Case

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

MAIN DIAGNOSIS

·   This is due to History of heavy vaginal bleeding for 3 months lasting for 7-8
days, consumes 6-8 pads per day fully soaked - AV/UB is the most
frequent symptom of endometrial hyperplasia and it is also common for
those with Endometrial Polyp
·   TVS: (2 weeks PTA):
o   thickened endometrium measuring  1.78 cm (Endometrial
Hyperplasia) with echogenic structure seemingly attached anteriorly
(Endometrial Polyp)
·   Final Histopath: 
o   Fragments consistent with Endometrial Polyp with Focal
Hyperplastic Changes
o   Simple Hyperplasia without atypia

PATHOGENESIS
Menstrual Cycle
 In the 1 phase of menstrual cycle (proliferative phase), estrogen
st

predominates and stimulates growth of endometrial glands and


stroma.  
 At the end of this phase, ovulation occurs where 1 ovarian follicle
expels the oocyte into fallopian tube and travels to uterus.
 In the 2 phase (secretory phase), the remaining structure of follicle,
nd

the luteal body, begins to secrete progesterone, causing the glands to


produce secretions that acts as nutrients for a supposed developing
embryo, and counteracting the effects of estrogen on endometrium by
stopping it’s growth.

Endometrial Hyperplasia
 Endometrial hyperplasia results when endometrium is exposed to high
levels of estrogen for a prolonged time and relative progesterone
insufficiency.
 The typical causes for endogenous estrogen excess include
anovulatory cycles (perimenopause, polycystic ovarian syndrome
(PCOS)), obesity, and estrogen secreting ovarian tumors.
 The exogenous causes include unopposed estrogen therapy, hormone
replacement therapy (HRT), and tamoxifen (used in breast cancer
treatment).

Endometrial Polyp
 An endometrial polyp or uterine polyp is an abnormal growth containing
glands, stroma and blood vessels projecting from the lining of the
uterus (endometrium).
 They are found during both reproductive and postmenopausal phases
of life, most common between age 40 and 49.
 They are believed to be related to estrogen stimulation, this may be as
a result of an increased concentration of oestrogen receptors (ERs),
predominantly ER-alpha in polyp glandular cells compared with normal
endometrium, and a decreased expression of progesterone receptors
(PRs) 
RISK FACTORS
 Age: The perimenopause is characterized by its variability in hormonal
level with increasing shortage of ovarian hormones and anovulation. In
the perimenopausal period an intermittent ovulation or even a chronic
anovulation take place, therefore the progesterone levels are low,
because there is no corpus luteum. The ovaries are still producing
oestrogen, which allows continued proliferation of the endometrium; the
thickened endometrium outgrows its blood supply, undergoes focal
necrosis and shedding begins. 
 Obesity: The extra adipose tissue converts androgens to estrogen
 Hyperestrogensim: The patient is on hyperestrogenism state where
there is unopposed estrogen due to obesity and the risk in
perimenopausal stage. 
 S/S of estrogen excess include…..
 But in the case, the patient only noted Heavy menses and weight
gain.  

You might also like